FDA Authorizes Expansion of Ampligen/FluMist Intranasal Clinical Trial Designed to Elicit Potential Protection Against Many Pre-Pandemic Influenza Viruses PHILADELPHIA, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced that its Phase 1/2 clinical trial at the University of Alabama...

Bird Flu Complacency Could Be Our Biggest Threat SCOTTSDALE, AZ--(Marketwire - June 13, 2007) - eFoodSafety.com (OTCBB: EFSF) -- For some, the threat of bird flu is most likely to occur in a sci-fi movie. But scientists and researchers say this...